Among them, only one case of GC with EBV-positive and -negative components was analyzed by p53 immunohistochemistry to investigate its molecular characteristics, which indicated the collision of EBV-positive and -negative components; the other cases were not molecularly analyzed [6–8]. The gene discussed is TP53; the disease is gastric cancer.